Paclitaxel Concept

subject area of

• A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel  Academic Article
• A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer  Academic Article
• A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab  Academic Article
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial  Academic Article
• A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer  Academic Article
• A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.  Academic Article
• A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.  Academic Article
• A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer  Academic Article
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Academic Article
• Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines  Academic Article
• Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.  Academic Article
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial  Academic Article
• Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients  Academic Article
• Comparative study of respiratory burst induced by phorbol ester and zymosan in human granulocytes  Academic Article
• Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice  Academic Article
• Complementary and Alternative Medicine Use Among Women Receiving Chemotherapy for Ovarian Cancer in 2 Patient Populations  Academic Article
• Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid)  Academic Article
• Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer  Academic Article
• Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.  Academic Article
• Effect of docetaxel (taxotere) on expression of radiation-induced lethal mutations in human cell lines  Academic Article
• First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study  Academic Article
• Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids  Academic Article
• Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer  Academic Article
• Getting to the heart of the problem: a case report on the use of emergency department ultrasonography in a patient with shortness of breath.  Academic Article
• IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).  Academic Article
• Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design  Academic Article
• Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)  Academic Article
• Induction of Apoptotic Cell Death Specifically in Rat and Human Cancer Cells by Pancratistatin  Academic Article
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells  Academic Article
• Interrelationships of endoplasmic reticulum, mitochondria, intermediate filaments, and microtubules—a quadruple fluorescence labeling study  Academic Article
• Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells  Academic Article
• Long-term benefit using DES in STEMI patients.  Academic Article
• Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: A Canadian experience  Academic Article
• Malignant pleural mesothelioma: a phase II trial with docetaxel  Academic Article
• Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology  Academic Article
• Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis  Academic Article
• Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study  Academic Article
• Naturally occurring resistance of bone marrow mononuclear and metastatic cancer cells to anticancer agents  Academic Article
• Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens  Academic Article
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study  Academic Article
• Paclitaxel Versus Sirolimus Stents in Diabetic and Nondiabetic Patients  Academic Article
• Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial  Academic Article
• Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer  Academic Article
• Pancratistatin: A natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis  Academic Article
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Academic Article
• Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel  Academic Article
• Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer  Academic Article
• Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Primary and Rescue Percutaneous Coronary Intervention With Paclitaxel-Eluting Stent Implantation in ST-Elevation Myocardial Infarction  Academic Article
• Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer  Academic Article
• Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29  Academic Article
• Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer  Academic Article
• Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18  Academic Article
• Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer  Academic Article
• Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study  Academic Article
• Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas  Academic Article
• Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events  Academic Article
• Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.  Academic Article
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants  Academic Article
• Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: an ultrastructural demonstration of an increased superficial chondroprotective layer.  Academic Article
• Taxol Involution of Collagen-Induced Arthritis: Ultrastructural Correlation with the Inhibition of Synovitis and Neovascularization  Academic Article
• Taxol encapsulation in poly(epsilon-caprolactone) microspheres  Academic Article
• Taxol resistant mutants of Chinese hamster ovary cells: Genetic biochemical, and cross-resistance studies  Academic Article
• Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)  Academic Article
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Academic Article
• The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line.  Academic Article
• Treatment of Restenosis with a Paclitaxel-Coated Balloon Catheter  Academic Article
• Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer  Academic Article